Stephen T. Abedon
Stephen T. Abedon
Professor of Microbiology, The Ohio State University
Bestätigte E-Mail-Adresse bei osu.edu - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Phage treatment of human infections
ST Abedon, SJ Kuhl, BG Blasdel, EM Kutter
Bacteriophage 1 (2), 66-85, 2011
8322011
Phage cocktails and the future of phage therapy
BK Chan, ST Abedon, C Loc-Carrillo
Future microbiology 8 (6), 769-783, 2013
6302013
Pros and cons of phage therapy
C Loc-Carrillo, ST Abedon
Bacteriophage 1 (2), 111-114, 2011
6282011
Phage therapy in clinical practice: treatment of human infections
E Kutter, D De Vos, G Gvasalia, Z Alavidze, L Gogokhia, S Kuhl, ...
Current pharmaceutical biotechnology 11 (1), 69-86, 2010
6272010
Bacteriophage host range and bacterial resistance
P Hyman, ST Abedon
Advances in applied microbiology 70, 217-248, 2010
5752010
Lysogeny in nature: mechanisms, impact and ecology of temperate phages
C Howard-Varona, KR Hargreaves, ST Abedon, MB Sullivan
The ISME journal 11 (7), 1511-1520, 2017
2932017
Lysis from without
ST Abedon
Bacteriophage 1 (1), 46-49, 2011
2602011
Bacteriophage latent-period evolution as a response to resource availability
ST Abedon, TD Herschler, D Stopar
Applied and environmental microbiology 67 (9), 4233-4241, 2001
2472001
Phage therapy pharmacology
ST Abedon, C Thomas-Abedon
Current pharmaceutical biotechnology 11 (1), 28-47, 2010
2352010
Bacteriophage ecology: population growth, evolution, and impact of bacterial viruses
ST Abedon
Cambridge University Press, 2008
2102008
Practical methods for determining phage growth parameters
P Hyman, ST Abedon
Bacteriophages, 175-202, 2009
2002009
Phage therapy pharmacology: phage cocktails
BK Chan, ST Abedon
Advances in Applied Microbiology, 1, 2012
1632012
Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and-sensitive monoclonal antibodies
CC Broder, PL Earl, D Long, ST Abedon, B Moss, RW Doms
Proceedings of the National Academy of Sciences 91 (24), 11699-11703, 1994
1631994
Experimental examination of bacteriophage latent-period evolution as a response to bacterial availability
ST Abedon, P Hyman, C Thomas
Applied and environmental microbiology 69 (12), 7499-7506, 2003
1402003
Bacteriophages and their enzymes in biofilm control
BK Chan, ST Abedon
Current pharmaceutical design 21 (1), 85-99, 2015
1362015
Selection for bacteriophage latent period length by bacterial density: a theoretical examination
ST Abedon
Microbial Ecology 18 (2), 79-88, 1989
1301989
Kinetics of phage-mediated biocontrol of bacteria
ST Abedon
Foodborne pathogens and disease 6 (7), 807-815, 2009
1292009
Phage evolution and ecology
ST Abedon
Advances in applied microbiology 67, 1-45, 2009
1222009
Editorial: Phage therapy: past, present and future
ST Abedon, P García, P Mullany, R Aminov
Frontiers in microbiology 8, 981, 2017
1142017
Bacteriophage plaques: theory and analysis
ST Abedon, J Yin
Bacteriophages, 161-174, 2009
1112009
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20